These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 21093979

  • 21. Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways.
    Kang N, Zhang JH, Qiu F, Tashiro S, Onodera S, Ikejima T.
    Cancer Lett; 2010 Aug 28; 294(2):147-58. PubMed ID: 20202741
    [Abstract] [Full Text] [Related]

  • 22. Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
    Kabra DG, Thiyagarajan M, Kaul CL, Sharma SS.
    Brain Res Bull; 2004 Feb 01; 62(5):425-33. PubMed ID: 15168908
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells.
    Kehe K, Raithel K, Kreppel H, Jochum M, Worek F, Thiermann H.
    Arch Toxicol; 2008 Jul 01; 82(7):461-70. PubMed ID: 18046540
    [Abstract] [Full Text] [Related]

  • 24. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
    Faderl S, Estrov Z, Kantarjian HM, Harris D, Van Q, Fokt I, Przewloka T, Godlewski C, Woynarowski JM, Priebe W.
    Anticancer Res; 2001 Jul 01; 21(6A):3777-84. PubMed ID: 11911247
    [Abstract] [Full Text] [Related]

  • 25. Doxorubicin-induced cell death requires cathepsin B in HeLa cells.
    Bien S, Rimmbach C, Neumann H, Niessen J, Reimer E, Ritter CA, Rosskopf D, Cinatl J, Michaelis M, Schroeder HW, Kroemer HK.
    Biochem Pharmacol; 2010 Nov 15; 80(10):1466-77. PubMed ID: 20709028
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells.
    Lieber J, Kirchner B, Eicher C, Warmann SW, Seitz G, Fuchs J, Armeanu-Ebinger S.
    Pediatr Blood Cancer; 2010 Dec 01; 55(6):1089-95. PubMed ID: 20680965
    [Abstract] [Full Text] [Related]

  • 27. GPI 6150 prevents H(2)O(2) cytotoxicity by inhibiting poly(ADP-ribose) polymerase.
    Zhang J, Lautar S, Huang S, Ramsey C, Cheung A, Li JH.
    Biochem Biophys Res Commun; 2000 Nov 30; 278(3):590-8. PubMed ID: 11095954
    [Abstract] [Full Text] [Related]

  • 28. Poly (ADP-ribose) polymerase inhibitor increases apoptosis and reduces necrosis induced by a DNA minor groove binding methyl sulfonate ester.
    Tentori L, Balduzzi A, Portarena I, Levati L, Vernole P, Gold B, Bonmassar E, Graziani G.
    Cell Death Differ; 2001 Aug 30; 8(8):817-28. PubMed ID: 11526435
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of PARP activity by PJ-34 leads to growth impairment and cell death associated with aberrant mitotic pattern and nucleolar actin accumulation in M14 melanoma cell line.
    Chevanne M, Zampieri M, Caldini R, Rizzo A, Ciccarone F, Catizone A, D'Angelo C, Guastafierro T, Biroccio A, Reale A, Zupi G, Caiafa P.
    J Cell Physiol; 2010 Feb 30; 222(2):401-10. PubMed ID: 19890834
    [Abstract] [Full Text] [Related]

  • 30. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.
    Eltze T, Boer R, Wagner T, Weinbrenner S, McDonald MC, Thiemermann C, Bürkle A, Klein T.
    Mol Pharmacol; 2008 Dec 30; 74(6):1587-98. PubMed ID: 18809672
    [Abstract] [Full Text] [Related]

  • 31. The effect of poly (adenosine diphosphate-ribose) polymerase inhibitors on biochemical changes in testicular ischemia-reperfusion injury.
    Bozlu M, Eskandari G, Cayan S, Canpolat B, Akbay E, Atik U.
    J Urol; 2003 May 30; 169(5):1870-3. PubMed ID: 12686864
    [Abstract] [Full Text] [Related]

  • 32. The effect of 3-aminobenzamide, inhibitor of poly(ADP-ribose) polymerase, on human osteosarcoma cells.
    De Blasio A, Musmeci MT, Giuliano M, Lauricella M, Emanuele S, D'Anneo A, Vassallo B, Tesoriere G, Vento R.
    Int J Oncol; 2003 Dec 30; 23(6):1521-8. PubMed ID: 14612922
    [Abstract] [Full Text] [Related]

  • 33. Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis.
    Noël G, Godon C, Fernet M, Giocanti N, Mégnin-Chanet F, Favaudon V.
    Mol Cancer Ther; 2006 Mar 30; 5(3):564-74. PubMed ID: 16546970
    [Abstract] [Full Text] [Related]

  • 34. PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility.
    Godon C, Cordelières FP, Biard D, Giocanti N, Mégnin-Chanet F, Hall J, Favaudon V.
    Nucleic Acids Res; 2008 Aug 30; 36(13):4454-64. PubMed ID: 18603595
    [Abstract] [Full Text] [Related]

  • 35. ATR signaling mediates an S-phase checkpoint after inhibition of poly(ADP-ribose) polymerase activity.
    Horton JK, Stefanick DF, Kedar PS, Wilson SH.
    DNA Repair (Amst); 2007 Jun 01; 6(6):742-50. PubMed ID: 17292679
    [Abstract] [Full Text] [Related]

  • 36. Predicting enhanced cell killing through PARP inhibition.
    Horton JK, Wilson SH.
    Mol Cancer Res; 2013 Jan 01; 11(1):13-8. PubMed ID: 23193155
    [Abstract] [Full Text] [Related]

  • 37. Cryptotanshinone potentiates the antitumor effects of doxorubicin on gastric cancer cells via inhibition of STAT3 activity.
    Wang J, Zhang G, Dai C, Gao X, Wu J, Shen L, Chen Z, Liu P.
    J Int Med Res; 2017 Feb 01; 45(1):220-230. PubMed ID: 28222632
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Poly(ADP-ribose) polymerase activity prevents signaling pathways for cell cycle arrest after DNA methylating agent exposure.
    Horton JK, Stefanick DF, Naron JM, Kedar PS, Wilson SH.
    J Biol Chem; 2005 Apr 22; 280(16):15773-85. PubMed ID: 15701627
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.